Immunocore

NASDAQ: IMCR · Real-Time Price · USD
32.92
0.04 (0.12%)
At close: Aug 18, 2025, 10:43 AM

Immunocore Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-28.87 -60.41 -52.32 -8.17
PEG Ratio
2.97 -2.36 0.74 -0.25
PS Ratio
4.75 13.39 15.01 40.53
PB Ratio
4.09 9.06 7.74 6.27
P/FCF Ratio
70.60 -1.34K -64.45 -8.22
P/OCF Ratio
56.59 1.14K -68.98 -8.28
OCF/S Ratio
0.08 0.01 -0.22 -4.89
Debt / Equity Ratio
1.20 0.23 0.25 0.37
Quick Ratio
4.36 3.77 4.70 4.60
Current Ratio
4.38 3.80 4.72 4.29
Asset Turnover
0.31 0.42 0.33 0.09
Interest Coverage
-3.74 -11.57 -7.32 -24.25
Return on Equity
-0.14 -0.15 -0.15 -0.77
Return on Assets
-0.05 -0.09 -0.09 -0.44
Return on Invested Capital
-0.09 -0.12 -0.11 -0.5
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.99 1.00 1.00 -1.76
Net Profit Margin
-0.16 -0.22 -0.29 -4.96
Pretax Profit Margin
-0.17 -0.24 -0.31 -5.31
Operating Profit Margin
-0.23 -0.24 -0.28 -5.1
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.23 -0.21 -0.27 -6.29